DUBLIN, Aug. 28, 2024 (GLOBE NEWSWIRE) — The “North American Biopreservation Market, by Country, Competition, Forecast, Opportunities, 2019-2029F” report has ResearchAndMarkets.com Provided.
The North American biopreservation market is expected to be valued at USD 686.8 million in 2023, and is expected to grow at a remarkable CAGR of 7.03% during the forecast period till 2029.
The biopreservation market has emerged as a key player in the life sciences and healthcare sector, revolutionizing the storage and maintenance of biological materials. Defined as the process of preserving cells, tissues, and organs outside of their natural environment to extend their viability, biopreservation has become an essential tool in various industries, including pharmaceutical, biotechnology, and healthcare.
The biopreservation market is driven by several key factors such as increasing demand for personalized medicine, rising investments in biobanking infrastructure, expanding regenerative medicine sector, etc. Advancements in cell therapy, gene therapy, and organ transplantation are further increasing the need for effective preservation solutions, propelling the market forward.
One notable trend shaping the field of biopreservation is the rise of cryopreservation technology. Cryopreservation involves storing biological samples at extremely low temperatures, usually below -130 degrees Celsius, to halt cellular activity and maintain the integrity of the sample. This method is widely used to preserve stem cells, embryos, and other valuable biological materials, contributing significantly to market growth.
The pharmaceutical and biotechnology sectors are major contributors to the biopreservation market. As these industries continue to explore innovative treatments and drug development approaches, the demand for reliable biopreservation methods is soaring. Biopreservation plays a vital role in maintaining the stability and efficacy of biological samples used in research and development, clinical trials, and manufacturing processes.
The applications of biopreservation are wide-ranging and cover a wide range of biological materials. In the medical field, the preservation of organs for transplantation has been a major advancement. Biopreservation ensures the viability of organs during transport and before transplantation, addressing the significant challenge of organ shortages. In addition to organ preservation, biobanking has become the foundation of medical research. Biobanks store and manage a variety of biological specimens, including blood, tissues, and DNA, for research purposes.
Rising biobanking efforts in North America, driven by collaborative research initiatives and precision medicine efforts, have contributed significantly to the expansion of the biopreservation market. The field of regenerative medicine, characterized by therapies aimed at repairing, replacing, and regenerating damaged tissues and organs, relies heavily on biopreservation. Stem cells, a key component of regenerative medicine, require precise preservation methods to maintain their therapeutic effects. As regenerative medicine continues to evolve, so too will the demand for advanced biopreservation solutions.
The biopreservation market is booming but faces challenges such as the high costs associated with advanced preservation technologies and the need for standardization of storage and transportation protocols. Addressing these challenges creates opportunities for market players to innovate and collaborate, facilitating the development of more cost-effective and universally applicable solutions.
The growing awareness of the importance of preserving biological materials coupled with the rise in chronic diseases has laid the foundation for the continued expansion of the biopreservation market. Market participants are poised to capitalize on this momentum by investing in research and development, strategic collaborations, and technological advancements. In conclusion, the biopreservation market is a dynamic and evolving field at the intersection of healthcare, biotechnology, and research. With the increasing focus on personalized medicine, regenerative therapies, and advanced drug development in North America, the role of biopreservation is becoming increasingly important.
Market trends over the next few years promise continued innovation, addressing challenges, and unlocking new possibilities for preserving biological assets. As the biopreservation market celebrates its first anniversary, it is a testament to the integral role it is playing in shaping the future of medicine and scientific exploration.
Key attributes:
| Report Attributes | detail |
| Number of pages | 125 |
| Forecast Period | 2023 – 2029 |
| Estimated market value in 2023 (USD) | $690 million |
| Market value forecast to 2029 (USD) | $1.03 billion |
| Compound Annual Growth Rate | 7.0% |
| Target area | North America |
Report Scope:
Key Market Players
- Agenta US
- Biomatrica Inc.
- BioLife Solutions Co., Ltd.
- MVE Biological Solutions
- LabVantage Solutions, Inc.
- Taylor Wharton International LLC
- Thermo Fisher Scientific
- Panasonic Corporation
- X-Therma Inc.
- Princeton Cryotech
North American Biopreservation Market, By Product:
North American Biopreservation Market, By Application:
- Regenerative Medicine
- Biobanking
- Drug Discovery
North American Biopreservation Market, by Country:
- united states of america
- Canada
- Mexico
For more information on this report, please visit: https://www.researchandmarkets.com/r/58x4pj
About ResearchAndMarkets.com
ResearchAndMarkets.com is a leading global source of international market research reports and market data providing the latest information on international markets, regional markets, key industries, top companies, new products and latest trends.
-
North American Biopreservation Market
#North #America #Biopreservation #Research #Report #Market #Size #Trends #Competition #Forecast #Opportunities #20192029F